UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
46.96
+1.36 (2.98%)
At close: Aug 7, 2026, 4:00 PM EDT
47.12
+0.16 (0.34%)
After-hours: Aug 7, 2026, 7:55 PM EDT
UroGen Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $50 → $60 | Buy | Reiterates | $50 → $60 | +27.77% | Aug 6, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $44 → $48 | Hold | Maintains | $44 → $48 | +2.21% | Aug 6, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $42 → $58 | Buy | Maintains | $42 → $58 | +23.51% | Aug 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 → $75 | Buy | Reiterates | $45 → $75 | +59.71% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $50 → $60 | Buy | Maintains | $50 → $60 | +27.77% | Aug 5, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $43 | Buy | Initiates | $43 | -8.43% | May 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 | Buy | Maintains | $40 | -14.82% | Apr 20, 2026 |
| Jefferies | Jefferies | Buy Initiates $40 | Buy | Initiates | $40 | -14.82% | Apr 9, 2026 |